Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose M Miro

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
Antimicrobial Agents and Chemotherapy|March 6, 2023
Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis<i>-oralis</i> Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-ResistanceNagendra N Mishra, Wessam Abdelhady, Ahmed M Elsayed, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|October 7, 2020
Tuberculosis in elderly patients in the city of Cali, Colombia: a hospital-based cohort studyJose Fernando García-Goez, Juan Diego Vélez, Barbara Lucía Mora, et al.
AIDS Care|November 26, 2015
The continuum of HIV care in CataloniaColin N J Campbell, Juan Ambrosioni, Jose M Miro, et al.
Current Microbiology|April 14, 2018
Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial StrategiesBrianne Zapata, Danya N Alvarez, Sabrina Farah, et al.
AIDS (London, England)|December 5, 2013
Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progressionElizabeth Hamlyn, Sarah Fidler, Wolfgang Stöhr, et al.
International Journal of Antimicrobial Agents|August 26, 2023
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review PanelEric Senneville, Guillermo Cuervo, Matthieu Gregoire, et al.
Expert Review of Anti-Infective Therapy|June 25, 2026
The endocarditis team: a reviewAoife Maher, Larry M Baddour, Sami El Dalati, et al.
Scandinavian Journal of Infectious Diseases|September 4, 2008
Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activityJose M Miro, Carlos Cervera, Cristina Garcia-de-la-Maria, et al.
Plos One|November 2, 2011
Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysisJose M Miro, Christian Manzardo, Cristina Mussini, et al.
The Lancet. HIV|April 29, 2021
Overview of SARS-CoV-2 infection in adults living with HIVJuan Ambrosioni, José Luis Blanco, Juliana M Reyes-Urueña, et al.
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|March 6, 2023
Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis<i>-oralis</i> Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-ResistanceNagendra N Mishra, Wessam Abdelhady, Ahmed M Elsayed, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|October 7, 2020
Tuberculosis in elderly patients in the city of Cali, Colombia: a hospital-based cohort studyJose Fernando García-Goez, Juan Diego Vélez, Barbara Lucía Mora, et al.
AIDS Care|November 26, 2015
The continuum of HIV care in CataloniaColin N J Campbell, Juan Ambrosioni, Jose M Miro, et al.
Current Microbiology|April 14, 2018
Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial StrategiesBrianne Zapata, Danya N Alvarez, Sabrina Farah, et al.
AIDS (London, England)|December 5, 2013
Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progressionElizabeth Hamlyn, Sarah Fidler, Wolfgang Stöhr, et al.
International Journal of Antimicrobial Agents|August 26, 2023
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review PanelEric Senneville, Guillermo Cuervo, Matthieu Gregoire, et al.
Expert Review of Anti-Infective Therapy|June 25, 2026
The endocarditis team: a reviewAoife Maher, Larry M Baddour, Sami El Dalati, et al.
Scandinavian Journal of Infectious Diseases|September 4, 2008
Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activityJose M Miro, Carlos Cervera, Cristina Garcia-de-la-Maria, et al.
Plos One|November 2, 2011
Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysisJose M Miro, Christian Manzardo, Cristina Mussini, et al.
The Lancet. HIV|April 29, 2021
Overview of SARS-CoV-2 infection in adults living with HIVJuan Ambrosioni, José Luis Blanco, Juliana M Reyes-Urueña, et al.
Pageof 16